Analysts Issue Forecasts for RARE FY2025 Earnings
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – William Blair issued their FY2025 earnings estimates for shares of Ultragenyx Pharmaceutical in a note issued to investors on Wednesday, May 28th. William Blair analyst S. Corwin anticipates that the biopharmaceutical company will post earnings per share of ($3.48) for the year. William Blair has a “Outperform” […]
More Stories
Vance to Lead US Delegation to Pakistan for Peace Talks With Iran
By Savannah Hulsey Pointer Vice President JD Vance and a team of negotiators are headed to Pakistan for peace talks...
How the High-Stakes Rescue Mission in Iran Unfolded
By John Haughey President Donald Trump was assured by the Pentagon and Central Intelligence Agency that the assembled array of...
Earnings Season Is About to Begin, and I Expect Positive Changes
By Louis Navellier We’re approaching another earnings season, starting in mid-April, when many of our stocks shine the brightest. Some...
These Detransitioners Sued for Medical Malpractice, but Will They Get Their Day in Court
By Darlene McCormick Sanchez Prisha Mosley thought that she would get her day in court when the North Carolina Legislature...
Cyber Crimes Costing Americans Nearly $21 Billion: FBI
By Naveen Athrappully The FBI released its 2025 Internet Crime Report, revealing that Americans were being defrauded to the tune...
Iran’s Revolutionary Guard Warns Oil Will Be Cut Off ‘For Years’
By Jack Phillips Iran’s Islamic Revolutionary Guard Corps warned on April 7 that the paramilitary group would attempt to block...